Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 11,7x - 12,9x | 12,3x |
| Selected Fwd EBITDA Multiple | 9,4x - 10,4x | 9,9x |
| Fair Value | 35.028₩ - 38.374₩ | 36.701₩ |
| Upside | 23,1% - 34,9% | 29,0% |
| Benchmarks | Ticker | Full Ticker |
| Philoptics Co., Ltd. | A161580 | KOSDAQ:A161580 |
| Exicon Co., Ltd. | A092870 | KOSDAQ:A092870 |
| Keeps Biopharma Inc. | A256940 | KOSDAQ:A256940 |
| LB Semicon Inc. | A061970 | KOSDAQ:A061970 |
| Tokai Carbon Korea Co., Ltd. | A064760 | KOSDAQ:A064760 |
| Duk San Neolux Co.,Ltd | A213420 | KOSDAQ:A213420 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| A161580 | A092870 | A256940 | A061970 | A064760 | A213420 | ||
| KOSDAQ:A161580 | KOSDAQ:A092870 | KOSDAQ:A256940 | KOSDAQ:A061970 | KOSDAQ:A064760 | KOSDAQ:A213420 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | NM- | NM- | NM- | -5.8% | 7.2% | NM- | |
| 3Y CAGR | NM- | NM- | NM- | -13.7% | -6.2% | 2.9% | |
| Latest Twelve Months | 30.8% | -444.9% | 95.6% | -7.5% | 17.2% | 49.9% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 2.6% | 1.9% | -47.2% | 23.2% | 40.0% | 28.2% | |
| Prior Fiscal Year | 5.3% | 4.6% | 4.9% | 20.1% | 36.1% | 25.5% | |
| Latest Fiscal Year | 5.1% | -41.7% | 6.9% | 17.2% | 34.8% | 29.4% | |
| Latest Twelve Months | 5.1% | -41.7% | 6.9% | 17.2% | 34.8% | 29.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.95x | 1.50x | 1.97x | 1.37x | 2.52x | 2.98x | |
| EV / LTM EBITDA | 38.6x | -3.6x | 28.6x | 8.0x | 7.3x | 10.1x | |
| EV / LTM EBIT | 57.8x | -3.0x | 40.4x | -32.9x | 8.6x | 12.1x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -3.6x | 8.0x | 38.6x | ||||
| Historical EV / LTM EBITDA | 10.1x | 14.6x | 23.9x | ||||
| Selected EV / LTM EBITDA | 11.7x | 12.3x | 12.9x | ||||
| (x) LTM EBITDA | 62,460 | 62,460 | 62,460 | ||||
| (=) Implied Enterprise Value | 731,282 | 769,771 | 808,260 | ||||
| (-) Non-shareholder Claims * | 79,601 | 79,601 | 79,601 | ||||
| (=) Equity Value | 810,883 | 849,372 | 887,860 | ||||
| (/) Shares Outstanding | 24.6 | 24.6 | 24.6 | ||||
| Implied Value Range | 33,012.49 | 34,579.43 | 36,146.37 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 33,012.49 | 34,579.43 | 36,146.37 | 28,450.00 | |||
| Upside / (Downside) | 16.0% | 21.5% | 27.1% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A161580 | A092870 | A256940 | A061970 | A064760 | A213420 | |
| Enterprise Value | 791,213 | 43,149 | 247,836 | 617,031 | 697,183 | 619,214 | |
| (+) Cash & Short Term Investments | 88,704 | 39,338 | 22,988 | 77,278 | 285,333 | 71,262 | |
| (+) Investments & Other | 8,430 | 52,162 | 15,110 | 3,729 | (0) | 31,282 | |
| (-) Debt | (66,408) | (7,374) | (55,737) | (387,515) | (649) | (22,849) | |
| (-) Other Liabilities | (83,875) | 0 | (13,087) | (116,236) | 0 | (96) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 738,065 | 127,275 | 217,109 | 194,288 | 981,868 | 698,815 | |
| (/) Shares Outstanding | 22.9 | 12.5 | 18.7 | 58.1 | 11.7 | 24.6 | |
| Implied Stock Price | 32,250.00 | 10,180.00 | 11,580.00 | 3,345.00 | 84,100.00 | 28,450.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 32,250.00 | 10,180.00 | 11,580.00 | 3,345.00 | 84,100.00 | 28,450.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |